Skip to content
Screener

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$142.28B+41.0%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$162.02M+24.8%
Altimmune logo
AltimmuneALT
$335.63M+113%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$608.24M-29.8%
Wave Life Sciences logo
Wave Life SciencesWVE
$558.32M+121%
Arrowhead Research logo
Arrowhead ResearchARWR
$2.27B+44.2%

Other financials

Income statement

See full
Revenue$364.3M+71.2%
Gross profit$43.5M
Operating income-$56.3M-19.3%
Net income-$57.9M-37.0%
EPS (diluted)-$1.99-4.7%

Balance sheet

See full
Cash & equivalents$292.9M+53.2%
Total debt$377.9M+179%
Total equity$523.7M-24.7%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$4.3M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.88B+57.6%
Enterprise value$11.96B+59.9%
P/S9.3×-5.4×

Profitability

See full
Gross margin96.5%
Operating margin-25.1%-9.2pp
Net margin-25.3%-8.8pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-53.3%+47.0pp
Debt / equity0.7×+0.5×
Current ratio3.2×-1.9×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050845
Line itemJune 30,2026December 31,2025
Intangible assets, net7,1877,381
Operating lease right-of-use assets5,5784,939
Other noncurrent assets21,108
Total assets$1,244,645$1,259,589
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$34,514$48,878
Accrued liabilities338,656260,392

Item 1. Financial Statements (Unaudited):

FAQ

What is Madrigal Pharmaceuticals, Inc.'s total assets?
Madrigal Pharmaceuticals, Inc. (MDGL) reported total assets of $1.24B in Q2 2026.
How has Madrigal Pharmaceuticals, Inc.'s total assets changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s total assets increased by 22.6% year-over-year, from $1.02B to $1.24B.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total assets?
Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total assets has grown at a 34.4% compound annual growth rate (CAGR), from $287M to $1.26B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Madrigal Pharmaceuticals, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude